Cellink AB (Germany) Today
| 49Z Stock | EUR 3.14 0.04 1.29% |
PerformanceVery Weak
| Odds Of DistressQuite High
|
Cellink AB is trading at 3.14 as of the 24th of July 2025. This is a 1.29% up since the beginning of the trading day. The stock's lowest day price was 3.14. Cellink AB has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 25th of April 2025 and ending today, the 24th of July 2025. Click here to learn more.
Cellink AB , a bio convergence company, designs and develops bioprinting, liquid handling, single-cell analysis, and live-cell imaging technologies in North America, Europe, Asia, and internationally. Cellink AB was founded in 2016 and is headquartered in Gothenburg, Sweden. The company has 69.07 M outstanding shares. More on Cellink AB
Moving against Cellink Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cellink Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cellink AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cellink AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, CoFounder | Erik Gatenholm |
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Cellink AB (49Z) is traded on Frankfurt Exchange in Germany and employs 1,210 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 450.38 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cellink AB's market, we take the total number of its shares issued and multiply it by Cellink AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cellink AB classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 69.07 M outstanding shares.
Cellink AB generates negative cash flow from operations
Check Cellink AB Probability Of Bankruptcy
Ownership AllocationCellink AB holds a total of 69.07 Million outstanding shares. Cellink AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cellink Ownership Details
Cellink AB Risk Profiles
Although Cellink AB's alpha and beta are two of the key measurements used to evaluate Cellink AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.06 | |||
| Standard Deviation | 2.9 | |||
| Variance | 8.43 | |||
| Risk Adjusted Performance | (0.02) |
Cellink Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cellink AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Cellink AB Corporate Management
Elected by the shareholders, the Cellink AB's board of directors comprises two types of representatives: Cellink AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cellink. The board's role is to monitor Cellink AB's management team and ensure that shareholders' interests are well served. Cellink AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cellink AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lotta Bus | Gen SVP | Profile | |
| Asa Hillsten | VP Relations | Profile | |
| Erica Bell | VP Officer | Profile | |
| Itedale Redwan | Chief Bioprinting | Profile | |
| Mikael Engblom | Interim Officer | Profile |
Other Information on Investing in Cellink Stock
Cellink AB financial ratios help investors to determine whether Cellink Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cellink with respect to the benefits of owning Cellink AB security.